Next Article in Journal
Pharmacologic Treatment Options for Insomnia in Patients with Schizophrenia
Next Article in Special Issue
Probiotics in the Treatment of Colorectal Cancer
Previous Article in Journal
The Role of Cannabis within an Emerging Perspective on Schizophrenia
Previous Article in Special Issue
MiR-663, a MicroRNA Linked with Inflammation and Cancer That Is under the Influence of Resveratrol
Review

Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer

Department of Urology, Nagasaki University Graduate School of Biomedical Sciences, 852-8501 Nagasaki, Japan
*
Author to whom correspondence should be addressed.
Medicines 2018, 5(3), 87; https://doi.org/10.3390/medicines5030087
Received: 9 July 2018 / Revised: 7 August 2018 / Accepted: 7 August 2018 / Published: 10 August 2018
(This article belongs to the Special Issue Natural Compounds as New Cancer Treatments)
Green tea and green tea polyphenols (GTPs) are reported to inhibit carcinogenesis and malignant behavior in several diseases. Various in vivo and in vitro studies have shown that GTPs suppress the incidence and development of bladder cancer. However, at present, opinions concerning the anticancer effects and preventive role of green tea are conflicting. In addition, the detailed molecular mechanisms underlying the anticancer effects of green tea in bladder cancer remain unclear, as these effects are regulated by several cancer-related factors. A detailed understanding of the pathological roles and regulatory mechanisms at the molecular level is necessary for advancing treatment strategies based on green tea consumption for patients with bladder cancer. In this review, we discuss the anticancer effects of GTPs on the basis of data presented in in vitro studies in bladder cancer cell lines and in vivo studies using animal models, as well as new treatment strategies for patients with bladder cancer, based on green tea consumption. Finally, on the basis of the accumulated data and the main findings, we discuss the potential usefulness of green tea as an antibladder cancer agent and the future direction of green tea-based treatment strategies for these patients. View Full-Text
Keywords: animal model; treatment; bladder cancer; epidemiology; green tea animal model; treatment; bladder cancer; epidemiology; green tea
MDPI and ACS Style

Miyata, Y.; Matsuo, T.; Araki, K.; Nakamura, Y.; Sagara, Y.; Ohba, K.; Sakai, H. Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer. Medicines 2018, 5, 87. https://doi.org/10.3390/medicines5030087

AMA Style

Miyata Y, Matsuo T, Araki K, Nakamura Y, Sagara Y, Ohba K, Sakai H. Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer. Medicines. 2018; 5(3):87. https://doi.org/10.3390/medicines5030087

Chicago/Turabian Style

Miyata, Yasuyoshi, Tomohiro Matsuo, Kyohei Araki, Yuichiro Nakamura, Yuji Sagara, Kojiro Ohba, and Hideki Sakai. 2018. "Anticancer Effects of Green Tea and the Underlying Molecular Mechanisms in Bladder Cancer" Medicines 5, no. 3: 87. https://doi.org/10.3390/medicines5030087

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop